Probiotic Supplementation in a Clostridium difficile-Infected Gastrointestinal Model Is Associated with Restoring Metabolic Function of Microbiota

Clostridium (C.) difficile-infection (CDI), a nosocomial gastrointestinal disorder, is of growing concern due to its rapid rise in recent years. Antibiotic therapy of CDI is associated with disrupted metabolic function and altered gut microbiota. The use of probiotics as an adjunct is being studied...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaisawat, Mohd Baasir, MacPherson, Chad W., Tremblay, Julien, Piano, Amanda, Iskandar, Michèle M., Tompkins, Thomas A., Kubow, Stan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023328/
https://www.ncbi.nlm.nih.gov/pubmed/31905795
http://dx.doi.org/10.3390/microorganisms8010060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023328/
https://www.ncbi.nlm.nih.gov/pubmed/31905795
http://dx.doi.org/10.3390/microorganisms8010060

Ejemplares similares